NCT04100642View on ClinicalTrials.gov

A Phase I Clinical Study of Hemay808

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

October 23, 2019

Study Completion Date

December 22, 2019

Conditions
Safety Issues
Interventions
DRUG

Hemay808

topical apply

DRUG

Placebo

topical apply

Trial Locations (1)

210042

Dermotology hospital, Chinese academy of medical science, Nanjing

All Listed Sponsors
lead

Tianjin Hemay Pharmaceutical Co., Ltd

INDUSTRY

NCT04100642 - A Phase I Clinical Study of Hemay808 | Biotech Hunter | Biotech Hunter